BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2856696)

  • 1. Renal effects of calcium blockade by tiapamil in normal and hypertensive subjects.
    Ribstein J; Cristol JP; Elkik F; Mimran A
    J Hypertens Suppl; 1985 Dec; 3(3):S165-7. PubMed ID: 2856696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
    J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal effects of nitrendipine monotherapy in essential hypertension.
    Thananopavarn C; Golub MS; Eggena P; Barrett JD; Sambhi MP
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1032-6. PubMed ID: 6085362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trandolapril, but not verapamil nor their association, restores the physiological renal hemodynamic response to adrenergic activation in essential hypertension.
    Lambertucci L; Di Serio C; Castellani S; Torrini M; Lotti E; Cristofari C; Masotti G; Marchionni N; Ungar A
    Transl Res; 2011 Jun; 157(6):348-56. PubMed ID: 21575919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of CS-905, a novel dihydropyridine calcium channel blocker, on arterial pressure, renal excretory function, and inner medullary blood flow in the rat.
    Yagil Y; Miyamoto M; Frasier L; Oizumi K; Koike H
    Am J Hypertens; 1994 Jul; 7(7 Pt 1):637-46. PubMed ID: 7946166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute renal effects of felodipine in hypertensive patients with kidney disease.
    Huysmans FT; van Hamersvelt HW; Sluiter HE; Wetzels JF; Koene RA
    Kidney Int Suppl; 1992 May; 36():S106-9. PubMed ID: 1614059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects.
    Leonetti G; Cuspidi C; Sampieri L; Terzoli L; Zanchetti A
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S319-24. PubMed ID: 6184561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive properties of tiapamil (RO 11-1781)--a new calcium antagonist--in patients with mild and moderate essential hypertension.
    Velasco M; Morillo J; Urbina A; Kögler P; Leishman B; Pasquier M; Hernändez-Pieretti O
    Int J Clin Pharmacol Res; 1987; 7(6):443-54. PubMed ID: 3440635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic administration of tiapamil prevents hemodynamic alterations accompanying development of high blood pressure in hypertensive rats.
    Hefti F; Gerold M; Holck M
    J Cardiovasc Pharmacol; 1984; 6(6):1192-200. PubMed ID: 6084779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
    Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
    Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease.
    Svarstad E; Myking O; Ofstad J; Iversen BM
    Scand J Urol Nephrol; 2002; 36(6):464-72. PubMed ID: 12623513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renovascular responses to high and low perfusate calcium steady-state experiments in the isolated perfused rat kidney with baseline vascular tone.
    Castelli I; Steiner LA; Kaufmann MA; Drop LJ
    J Surg Res; 1996 Feb; 61(1):51-7. PubMed ID: 8769942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal effects of calcium antagonists with special reference to manidipine hydrochloride.
    Rodicio JL
    Blood Press Suppl; 1996; 5():10-5. PubMed ID: 8973787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute and chronic effects of a new calcium blocker, nicardipine, on renal hemodynamics in arterial hypertension].
    Chaignon M; Bellet M; Lucsko M; Rapoud C; Guédon J
    Arch Mal Coeur Vaiss; 1985 Oct; 78(11):1642-6. PubMed ID: 3938234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal actions of calcium antagonists.
    Sterzel RB
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S17-22. PubMed ID: 2455125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal hemodynamics in hypertensive renal allograft recipients: effects of calcium antagonists and ACE inhibitors.
    Grekas D; Dioudis C; Kalevrosoglou I; Alivanis P; Derveniotis V; Tourkantonis A
    Kidney Int Suppl; 1996 Jun; 55():S97-100. PubMed ID: 8743523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal function and hemodynamic studies in low- and normal-renin essential hypertension.
    Bauer JH; Brooks CS; Burch RN
    Arch Intern Med; 1982 Jul; 142(7):1317-23. PubMed ID: 7046671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis.
    Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Ozawa Y; Saruta T
    Clin Sci (Lond); 2001 Oct; 101(4):421-7. PubMed ID: 11566080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.